Results 111 to 120 of about 519,893 (158)

Comparison of Immune Responses and Safety Profiles Following a Fourth Heterologous Dose (Second Booster) with mRNA-1273 in Individuals Previously Vaccinated with Two Doses of CoronaVac and a Booster Dose of Either AZD1222 or BNT162b2. [PDF]

Vaccines (Basel)
Tangsathapornpong A, Nanthapisal S, Fukpho W, Bunjoungmanee P, Neamkul Y, Pontan K, Boonyarangkul A, Wanpen S, Thongphubeth K, Tharabenjasin P, Jaru-Ampornpan P.   +10 more
europepmc   +1 more source

Structural serology of polyclonal antibody responses to mRNA-1273 and NVX-CoV2373 COVID-19 vaccines. [PDF]

Cell Rep
Bangaru S, Jackson AM, Copps J, Fernández-Quintero ML, Torres JL, Richey ST, Nogal B, Sewall LM, Torrents de la Peña A, Rehman A, Guebre-Xabier M, Girard B, Das R, Corbett-Helaire KS, Seder RA, Graham BS, Edwards DK, Patel N, Smith G, Ward AB.   +19 more
europepmc   +1 more source

Longitudinal Comparison of Three T-Cell Assays and Three Antibody Assays Against SARS-CoV-2 Following Homologous mRNA-1273/mRNA-1273/mRNA-1273 and Heterologous ChAdOx1/ChAdOx1/BNT162b2 Vaccination: A Prospective Cohort in Naïve Healthcare Workers. [PDF]

Vaccines (Basel)
Lee H, Ko GY, Lee J, Bae H, Ryu JH, Jung J, Kang H, Lee R, Lee DG, Oh EJ.   +9 more
europepmc   +1 more source

The role of intestinal microbiota in the humoral response to SARS-CoV-2 after mRNA-1273 vaccination. [PDF]

Sci Rep
Tarriño M, Gutiérrez-Bautista JF, Durán MJO, Garcia-Diaz A, Cabrera-Serrano AJ, Sainz J, Cobo F, Rodriguez T, Reguera JA, Bernal M, López-Nevot MÁ, Sampedro A.   +11 more
europepmc   +1 more source

Evaluation of Cellular Immune Responses After mRNA-1273 Vaccination in Children 6 Months to 11 Years of Age. [PDF]

J Infect Dis
Rostad CA, Campbell JD, Paulsen GC, Ghamloush SS, Xu W, Zheng L, McElrath MJ, De Rosa SC, Girard B, Das R, Anderson EJ, Creech CB.   +11 more
europepmc   +1 more source

Immunostimulatory/Immunodynamic model of mRNA-1273 to guide pediatric vaccine dose selection. [PDF]

CPT Pharmacometrics Syst Pharmacol
Ivaturi V, Attarwala H, Deng W, Ding B, Schnyder Ghamloush S, Girard B, Iqbal J, Minnikanti S, Zhou H, Miller J, Das R.   +10 more
europepmc   +1 more source

Evaluating the Effectiveness of 2024-2025 Seasonal mRNA-1273 Vaccination Against COVID-19-Related Hospitalizations and Medically Attended COVID-19 Among Adults Aged ≥ 18 years in the United States: An Observational Matched Cohort Study. [PDF]

Infect Dis Ther
Vicic N, Bogdanov A, Zheng Z, Ryan T, Zeng N, Joshi K, Lu T, Bonafede M, Araujo AB, Wilson A.   +9 more
europepmc   +1 more source

Population-based cohort study assessing the effectiveness of maternal BNT162b2/mRNA-1273 vaccination against infant coronavirus disease 2019 outcomes during Omicron predominance: The VENUS study. [PDF]

Hum Vaccin Immunother
Ishiguro C, Mimura W, Oda F, Maeda M, Fukuda H.   +4 more
europepmc   +1 more source

A genome-wide association study identifies new loci associated with response to SARS-CoV-2 mRNA-1273 vaccine in a cohort of healthy healthcare workers. [PDF]

Front Immunol
Cabrera-Serrano AJ, Ruiz-Durán L, Gutiérrez-Bautista JF, Carretero-Fernández M, Ter Horst R, Li Y, Reyes-Zurita FJ, García-Verdejo FJ, Netea MG, Sánchez-Rovira P, López-Nevot MÁ, Sampedro A, Sainz J.   +12 more
europepmc   +1 more source

Initial Effectiveness of mRNA-1273 Against SARS-CoV-2 Infection and Hospitalization in Young Children. [PDF]

Open Forum Infect Dis
Aglipay M, Maguire JL, Swayze S, Tuite A, Mamdani M, Keown-Stoneman C, Birken CS, Kwong JC.   +7 more
europepmc   +1 more source